Literature DB >> 19488871

Application of oligonucleotides arrays for coincident comparative genomic hybridization, ploidy status and loss of heterozygosity studies in human cancers.

John K Cowell1, Ken C Lo.   

Abstract

Many oligonucleotide arrays comprise of spotted short oligonucleotides from throughout the genome under study. Hybridization of tumor DNA samples to these arrays will provide copy number estimates at each reference point with varying degrees of accuracy. In addition to copy number changes, however, tumors often undergo loss of heterozygosity for specific regions of the genome without copy number changes and these genetic changes can only be identified using arrays that identify polymorphic alleles at each reference point. In addition, because the hybridization intensity can be measured at each of the allelic variants, allelic ratios can be established which give indications of ploidy status in the tumor which is not generally possible using most other oligonucleotide array designs. The only arrays currently available that simultaneously report copy number, ploidy, and loss of heterozygosity are the Affymetrix SNP mapping arrays. In this review, the features of the SNP mapping arrays are described and computational tools explored which allow the maximum genetic information to be extracted from the experiment. Although the methodologies to generate the SNP data are now well established, approaches to interpret the data are only just being developed. From our experience using these arrays, we provide insights into how to evaluate the SNP data to report copy number changes, loss of heterozygosity, and ploidy in the same tumor samples using a single array.

Entities:  

Mesh:

Year:  2009        PMID: 19488871     DOI: 10.1007/978-1-60327-192-9_5

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  8 in total

1.  Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences.

Authors:  Leonora Balaj; Ryan Lessard; Lixin Dai; Yoon-Jae Cho; Scott L Pomeroy; Xandra O Breakefield; Johan Skog
Journal:  Nat Commun       Date:  2011-02-01       Impact factor: 14.919

2.  Screening of cerebral infarction-related genetic markers using a Cox regression analysis between onset age and heterozygosity at randomly selected short tandem repeat loci.

Authors:  Liu Hui; Tian Jun; Ye Jing; Weijian Yu
Journal:  J Thromb Thrombolysis       Date:  2012-05       Impact factor: 2.300

Review 3.  Using genetics and genomics strategies to personalize therapy for cancer: focus on melanoma.

Authors:  Katherine L Nathanson
Journal:  Biochem Pharmacol       Date:  2010-04-20       Impact factor: 5.858

4.  Interpreting aCGH-defined karyotypic changes in gliomas using copy number status, loss of heterozygosity and allelic ratios.

Authors:  John K Cowell; Ken C Lo; Jesse Luce; Lesleyann Hawthorn
Journal:  Exp Mol Pathol       Date:  2009-10-07       Impact factor: 3.362

5.  Analysis of wilms tumors using SNP mapping array-based comparative genomic hybridization.

Authors:  Lesleyann Hawthorn; John K Cowell
Journal:  PLoS One       Date:  2011-04-22       Impact factor: 3.240

6.  Copy number variation across European populations.

Authors:  Wanting Chen; Caroline Hayward; Alan F Wright; Andrew A Hicks; Veronique Vitart; Sara Knott; Sarah H Wild; Peter P Pramstaller; James F Wilson; Igor Rudan; David J Porteous
Journal:  PLoS One       Date:  2011-08-04       Impact factor: 3.240

7.  Circulating Tumor DNA: Less Invasive, More Representative Method to Unveil the Genomic Landscape of Newly Diagnosed Multiple Myeloma Than Bone Marrow Aspirates.

Authors:  Yang Liu; Jiapei Guo; Yuting Yi; Xuan Gao; Lei Wen; Wenbing Duan; Zhaohong Wen; Yaoyao Liu; Yanfang Guan; Xuefeng Xia; Ling Ma; Rong Fu; Lihong Liu; Xiaojun Huang; Qing Ge; Jin Lu
Journal:  Cancers (Basel)       Date:  2022-10-07       Impact factor: 6.575

8.  Circulating tumor DNA analysis depicts subclonal architecture and genomic evolution of small cell lung cancer.

Authors:  Jingying Nong; Yuhua Gong; Yanfang Guan; Xin Yi; Yuting Yi; Lianpeng Chang; Ling Yang; Jialin Lv; Zhirong Guo; Hongyan Jia; Yuxing Chu; Tao Liu; Ming Chen; Lauren Byers; Emily Roarty; Vincent K Lam; Vassiliki A Papadimitrakopoulou; Ignacio Wistuba; John V Heymach; Bonnie Glisson; Zhongxing Liao; J Jack Lee; P Andrew Futreal; Shucai Zhang; Xuefeng Xia; Jianjun Zhang; Jinghui Wang
Journal:  Nat Commun       Date:  2018-08-06       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.